Abstract:[Objective] To evaluate the clinical efficacy of the proximal femur bionic nail (PFBN) versus proximal femoral nail anti-ro-tation (PFNA) in the treatment of intertrochanteric fractures in elderly patients. [Methods] A comprehensive literature search was conduct-ed in databases including PubMed, Cochrane Library, EMBASE, Web of Science, CNKI, Wanfang, VIP and CBM. The search period wasfrom the inception of the databases to November 2023. Literature quality assessment and data extraction were performed independently bytwo researchers, and then RevMan 5.3 software was used for data analysis. [Results] Four studies involving a total of 236 patients, includ-ing 118 in the PFBN group and 118 in the PFNA group, were enrolled into this study. As results of the meta analysis, PFBN group had sig-nificant advantages over the PFNA group in terms of fracture healing time (MD=-0.43, 95%CI -0.71~-0.14, P=0.003), weight-bearingtime (MD=-6.16, 95%CI -9.14~-3.18, P<0.001), final Harris score (MD=0.52, 95%CI 0.11~0.93, P=0.01), and complications (OR=0.21,95%CI 0.05~0.91, P=0.04). However, the PFBN group had a longer surgical time (MD=0.82, 95%CI 0.08~1.55, P=0.03) compared to thePFNA group. There were no statistically significant differences between the two groups in terms of intraoperative blood loss and hospitalstay. [Conclusion] The PFBN demonstrates advantages in terms of earlier weight-bearing activity, faster fracture healing, better hip func-tion recovery, and lower complications rate over the PFNA in the treatment of intertrochanteric fractures in elderly. However, PFBN re-quired longer surgical time compared to PFNA.